Login / Signup

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.

Michael RuzickaSonja WurmLars Hartwin LindnerMartin DreylingMichael von Bergwelt-BaildonStefan BoeckClemens Giessen-JungValeria MilaniHans Joachim StemmlerMarion SubkleweOliver WeigertKarsten Spiekermann
Published in: Infection (2022)
Thrombocytopenia after COVID-19 vaccination should trigger a diagnostic workup to exclude vaccine-induced immune thrombotic thrombocytopenia (VITT) and, if confirmed, VA-ITP should be treated according to current ITP guidelines. Re-vaccination of patients seems feasible under close monitoring of blood counts and using a vaccine that differs from the one triggering the initial episode of VA-ITP.
Keyphrases
  • sars cov
  • end stage renal disease
  • newly diagnosed
  • coronavirus disease
  • ejection fraction
  • chronic kidney disease
  • respiratory syndrome coronavirus
  • peritoneal dialysis
  • diabetic rats
  • high glucose
  • stress induced